| Abstrakt: |
A recent study conducted by researchers at the Fourth Military Medical University in Shaanxi, China, explores targeted therapies for advanced urothelial carcinoma (UC), a major type of bladder cancer. The study highlights the limited efficacy of current treatment options, such as chemotherapy and immunotherapy, and emphasizes the need for novel therapeutic approaches. The researchers discuss the molecular alterations associated with UC targeted therapy and potential interventions for treatment, including the use of novel targeted drugs in combination therapy. The study provides valuable insights into the landscape of targeted therapies for advanced urothelial carcinoma. [Extracted from the article] |
